An Open Label Study of L059 Intravenous (IV) in Japanese Epilepsy Subjects With Partial Onset Seizures
|ClinicalTrials.gov Identifier: NCT01407523|
Recruitment Status : Completed
First Posted : August 2, 2011
Results First Posted : March 7, 2013
Last Update Posted : March 7, 2013
|Study Design||Intervention Model: Single Group Assignment; Masking: None (Open Label); Primary Purpose: Treatment|
Partial Onset Seizures
This study started to enroll subjects in July 2011 in order to end up with 4 centers in Japan.
16 subjects were treated and completed the study. All 16 subjects are included in the Safety Set.
|Pre-assignment Details||The Safety Set (SS) consisted of all subjects who started Levetiracetam intravenous (LEV IV) infusion after they had signed and dated the Informed Consent form. Participant Flow and Baseline Characteristics refer to the Safety Set (SS).|